Company: NCEL
Filing Date: 2025-09-25
Form Type: F-1
Source: 0001213900-25-091697
Chunk: 6

Company: NewcelX Ltd.
Filing Date: 2025-09-25
Form: F-1
Chunk 6
---
us. The website address has been
included in this prospectus solely as an inactive textual reference.

Common Shares Purchase Agreement with Alpha

On March 31, 2025, we entered
into the Purchase Agreement with the Selling Shareholder relating to a committed equity facility. Pursuant to the Purchase Agreement,
we have the right from time-to-time at our option to sell to the Selling Shareholder up to $25.0 million of Common Shares subject to certain
conditions and limitations set forth therein.

Sales of the Common Shares
to the Selling Shareholder under the Purchase Agreement, and the timing of any sales, will be determined by us from time-to-time in our
sole discretion and will depend on a variety of factors, including, among other things, the market conditions and the trading price of
the Common Shares and determinations by us regarding the use of proceeds of such Common Shares. The net proceeds from any sales under
the Purchase Agreement will depend on the frequency with, and prices at which the Common Shares are sold to the Investor. We expect to
use the proceeds from any sales under the Purchase Agreement for working capital and general corporate purposes.

<div align='center'>1</div>

Upon the initial satisfaction
of the conditions to the Selling Shareholder’s obligation to purchase Common Shares set forth in the Purchase Agreement (the “Commencement”),
including a registration statement registering the resale by the Investor of the Common Shares under the Securities Act that may be sold
to it by us under the Purchase Agreement, is declared effective by the SEC and a final prospectus relating thereto is filed with the SEC,
we will have the right, but not the obligation, from time-to-time to its sole discretion until the first day of the month next following
the 36-month period from and after Commencement, to direct the Investor to purchase up to a specified maximum amount of Common Shares
as set forth in the Purchase Agreement by delivering written notice to the Investor prior to the commencement of trading on any trading
day. The purchase price of the Common Shares that we elect to sell to the Selling Shareholder pursuant to the Purchase Agreement will
be 95% of the volume weighted average price of the Common Shares during the applicable purchase date on which we have timely delivered
written notice to the Selling Shareholder directing it to purchase Common Shares under the Purchase Agreement (a “VWAP Purchase”).

In connection with the Purchase Agreement, we also agreed to issue
the Selling Shareholder the Commitment Shares, and as such we